Skip to content

Laboratoire Colman

Active
Private limited company (pre-2019)founded 1954active for 72 yearsRue Victor Garin(L.L) 63, 7100 La Louvière, BelgiumKBO/BCE: BE 0401.753.610
Summary

The computed 12-month bankruptcy probability of Laboratoire Colman is 6.5% (elevated). For Laboratoire Colman, at least two annual filings are missing. The 2023 annual accounts show equity of €8,320 and a net result of -€12,676. Equity has been shrinking by about 31% per year since 2018. If that trend continues, it turns negative around financial year 2024. Its solvency ranks better than 34% of 14,746 sector peers (NACE 46, financial year 2023). The company has been active since 1954 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

Source: KBO
Status
Active since 15-02-1954 Normal situation
Activity
Wholesale of pharmaceutical and medical goods NACE 46460
Establishment unit
2.003.725.634 7100 La Louvière, since 01-02-1954
Financial year end
31 December
Peppol
Reachable since 27-02-2026

Board and ownership

Board

Financial position

Bankruptcy probabilitywithin 12 months
6.5%
2023 figures too old to score
Annual accounts 2023
Gross margin
-€567
Loss
€12,676
▼ 17.7%
Equity
€8,320
▼ 60.4%
Total assets
€42,585
▼ 1.9%
Staff
0.3 FTE
  • 2024 accounts not filed, 460 days past the deadline
Turnover not published (micro format)
Signalsraises riskFigures for financial year 2023 (filed on 11-12-2024)2 financial years not filed after the legal deadline; last filed accounts filed 127 days late; 1 of the last 3 accounts lateSector: Wholesale trade (NACE 46)Two or more financial years not filed2023 accounts filed 127 days latelowers riskFounded in 1954Show the evidence

Bankruptcy probability

No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Bankruptcy probability: Elevated
Filing: At least two annual filings are missing
Financial strength, FY 2023 · tick: 2022
Weak
Solvency 45-28
equity 19.5% of total assets
Liquidity 20-54
short-term debt 80.5% · cash 10.8%
Profitability 0=
return on assets -29.8%
Bankruptcy probability within 12 months
6.5% Elevated
0%0.5%1.5%4%10%≥ 25%

About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,899 companies, NACE 46, micro)
Last 24 months 12-2024: 7.0%highest value 01-2025: 4.9%▼ -2.1 percentage points vs 12-2024 02-2025: 1.8%▼ -3.1 percentage points vs 01-2025 03-2025: 1.8%● unchanged vs 02-2025 04-2025: 2.0%▲ +0.2 percentage points vs 03-2025 05-2025: 2.0%● unchanged vs 04-2025 06-2025: 0.8%▼ -1.2 percentage points vs 05-2025lowest value 07-2025: 1.0%▲ +0.2 percentage points vs 06-2025 08-2025: 1.4%▲ +0.4 percentage points vs 07-2025 09-2025: 1.5%▲ +0.1 percentage points vs 08-2025 10-2025: 1.9%▲ +0.4 percentage points vs 09-2025 11-2025: 2.0%▲ +0.1 percentage points vs 10-2025 12-2025: 2.6%▲ +0.6 percentage points vs 11-2025 01-2026: 5.0%▲ +2.4 percentage points vs 12-2025 02-2026: 5.0%● unchanged vs 01-2026 03-2026: 5.3%▲ +0.3 percentage points vs 02-2026 04-2026: 4.8%▼ -0.5 percentage points vs 03-2026 05-2026: 4.8%● unchanged vs 04-2026 06-2026: 4.8%● unchanged vs 05-2026 07-2026: 4.8%● unchanged vs 06-2026 08-2026: 6.5%▲ +1.7 percentage points vs 07-2026 09-2026: 6.5%● unchanged vs 08-2026 10-2026: 6.5%● unchanged vs 09-2026 11-2026: 6.5%● unchanged vs 10-2026
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2023 (filed on 11-12-2024)
NBB · annual accounts
raises risk · 2 financial years not filed after the legal deadline; last filed accounts filed 127 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Founded in 1954
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Wholesale trade (NACE 46)
KBO
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filings
Position against the passed deadline
31-12-2024 year end31-07-2025 deadline03-11-2026 today
raises risk · 2023 accounts filed 127 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 05-12-2024, 127 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
127 days late
2022
26 days early
2021
74 days early
2020
6 days late
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 6 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 5 loss-making years in a rowloss in financial year 2023 -€12,676 View
  • Caution: Lower net result than 84% of companies in wholesale tradesector median €5,190 · 14,740 companies -€12,676 View

Recent changes

  1. · Gazette deed Registered office moved from La Louvière to La Louviere
  2. · Gazette deed Registered office moved from La Louvière to La LouviereResignation: GURNE Yves (director) · Appointment: FASCELLA Antonio (director)
All 13 events

Comparable companies

These companies have the same main activity as Laboratoire Colman: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €17,600 and €92,800, founded between 1968 and 1990.

CompanyTotal assetsGross margin
Laboratoire Colman La Louvière€42,585-€567
Laboratoire du Docteur Vétérinaire Domicent Mons€37,195€2,265
FREMED Kortrijk€21,724-€2,604
EUROPHARMACEUTICALS Ukkel€54,573-€15,369
BIOMEDECINE Vilvoorde€27,357-€6,132
Prothéses d'Oreille Utilitaires dans la Recherche et la Technologie Manage€17,598€1,418
GLOBEX INTERNATIONAL Antwerpen€92,829-€13,905
Full comparison

Key facts about Laboratoire Colman

What is the company number of Laboratoire Colman?
The company number of Laboratoire Colman is 0401.753.610. The VAT number is the same number with BE in front: BE 0401.753.610.
Where is Laboratoire Colman based?
The registered office is at Rue Victor Garin(L.L) 63, 7100 La Louvière.Company details
What does Laboratoire Colman do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Laboratoire Colman?
The legal form of Laboratoire Colman is Private limited company (pre-2019) (BVBA).
When was Laboratoire Colman founded?
Laboratoire Colman was founded on 15-02-1954.
Is Laboratoire Colman still active?
Yes, Laboratoire Colman is an active enterprise in the KBO register.
How many employees does Laboratoire Colman have?
Laboratoire Colman had an average of 0.3 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of Laboratoire Colman?
The annual accounts for financial year 2023 state no turnover. The micro format does not require it.
Is Laboratoire Colman profitable?
In financial year 2023, Laboratoire Colman made a loss of €12,676.
Where can I find the annual accounts of Laboratoire Colman?
Laboratoire Colman filed 47 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.